Raymond James Downgrades Acceleron Pharma (XLRN) to Market Perform

October 4, 2021 6:24 AM EDT
Get Alerts XLRN Hot Sheet
Price: $178.75 --0%

Rating Summary:
    11 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 5 | Down: 13 | New: 13
Join SI Premium – FREE

Raymond James analyst Danielle Brill downgraded Acceleron Pharma (NASDAQ: XLRN) from Strong Buy to Market Perform.

For an analyst ratings summary and ratings history on Acceleron Pharma click here. For more ratings news on Acceleron Pharma click here.

Shares of Acceleron Pharma closed at $174.35 yesterday.

You May Also Be Interested In

Related Categories